GlassScriptPhysician profile
Dana Rose Ambler
NPI 1396943965
$1,136.87
in general payments reported to CMS, 2019-2025
12 companies · $28.99 in 2025
The $28.99 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $162 · 2021: $110 · 2022: $161 · 2023: $82.97 · 2024: $214 · 2025: $28.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $489.71 | 2019-2024 | Menopur |
| Organon LLC | $172.58 | 2021-2025 | Follistim Aq |
| Abbvie INC. | $138.00 | 2019-2023 | Synthroid |
| Amneal Pharmaceuticals LLC | $72.38 | 2021-2023 | Unithroid |
| Emd Serono, INC. | $67.41 | 2019-2024 | |
| Meditrina | $45.00 | 2021-2025 | |
| Coopersurgical, INC. | $43.19 | 2021-2022 | |
| Hologic Sales and Service, LLC | $37.30 | 2019-2022 | |
| Galen US INC | $22.29 | 2020 | |
| Daiichi Sankyo INC. | $17.69 | 2019 | |
| Merck Sharp & Dohme LLC | $17.57 | 2020 | |
| Cook Medical LLC | $13.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Ambler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.